These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 18528302)
1. T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors. Comoli P; Schilham MW; Basso S; van Vreeswijk T; Bernardo ME; Maccario R; van Tol MJ; Locatelli F; Veltrop-Duits LA J Immunother; 2008; 31(6):529-36. PubMed ID: 18528302 [TBL] [Abstract][Full Text] [Related]
2. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation. Feuchtinger T; Richard C; Joachim S; Scheible MH; Schumm M; Hamprecht K; Martin D; Jahn G; Handgretinger R; Lang P J Immunother; 2008; 31(2):199-206. PubMed ID: 18481389 [TBL] [Abstract][Full Text] [Related]
3. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Feuchtinger T; Matthes-Martin S; Richard C; Lion T; Fuhrer M; Hamprecht K; Handgretinger R; Peters C; Schuster FR; Beck R; Schumm M; Lotfi R; Jahn G; Lang P Br J Haematol; 2006 Jul; 134(1):64-76. PubMed ID: 16803570 [TBL] [Abstract][Full Text] [Related]
4. Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(HELPER) cells following stem cell transplantation. Serangeli C; Bicanic O; Scheible MH; Wernet D; Lang P; Rammensee HG; Stevanovic S; Handgretinger R; Feuchtinger T Virology; 2010 Feb; 397(2):277-84. PubMed ID: 19962170 [TBL] [Abstract][Full Text] [Related]
5. Human CD4+ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus. Veltrop-Duits LA; Heemskerk B; Sombroek CC; van Vreeswijk T; Gubbels S; Toes RE; Melief CJ; Franken KL; Havenga M; van Tol MJ; Schilham MW Eur J Immunol; 2006 Sep; 36(9):2410-23. PubMed ID: 16933360 [TBL] [Abstract][Full Text] [Related]
6. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. Feuchtinger T; Richard C; Pfeiffer M; Neuhäuser F; Lücke J; Handgretinger R; Greil J; Bader P; Klingebiel T; Schlegel PG; Jahn G; Niethammer D; Lang P Klin Padiatr; 2005; 217(6):339-44. PubMed ID: 16307420 [TBL] [Abstract][Full Text] [Related]
7. Adoptive immunotherapy with antigen-specific T cells during extracorporeal membrane oxygenation (ECMO) for adenovirus-related respiratory failure in a child given haploidentical stem cell transplantation. Di Nardo M; Li Pira G; Amodeo A; Cecchetti C; Giorda E; Ceccarelli S; Brescia LP; Pirozzi N; Rutella S; Locatelli F; Bertaina A Pediatr Blood Cancer; 2014 Feb; 61(2):376-9. PubMed ID: 24039155 [TBL] [Abstract][Full Text] [Related]
8. Generation of cytotoxic T-cell lines using overlapping pentadecapeptides derived from conserved regions of the adenovirus hexon protein. Zhu F; Xu H; Tsao A; Margolis DA; Keever-Taylor CA J Gen Virol; 2010 Jun; 91(Pt 6):1577-89. PubMed ID: 20130135 [TBL] [Abstract][Full Text] [Related]
9. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. van Tol MJ; Kroes AC; Schinkel J; Dinkelaar W; Claas EC; Jol-van der Zijde CM; Vossen JM Bone Marrow Transplant; 2005 Jul; 36(1):39-50. PubMed ID: 15908981 [TBL] [Abstract][Full Text] [Related]
10. Transfer of Hexon- and Penton-selected adenovirus-specific T cells for refractory adenovirus infection after haploidentical stem cell transplantation. Schultze-Florey RE; Tischer-Zimmermann S; Heuft HG; Priesner C; Lamottke B; Heim A; Sauer M; Sykora KW; Blasczyk R; Eiz-Vesper B; Maecker-Kolhoff B Transpl Infect Dis; 2020 Feb; 22(1):e13201. PubMed ID: 31643129 [TBL] [Abstract][Full Text] [Related]
11. Rapid generation of full clinical-grade human antiadenovirus cytotoxic T cells for adoptive immunotherapy. Aïssi-Rothé L; Decot V; Venard V; Jeulin H; Salmon A; Clement L; Kennel A; Mathieu C; Dalle JH; Rauser G; Cambouris C; de Carvalho M; Stoltz JF; Bordigoni P; Bensoussan D J Immunother; 2010 May; 33(4):414-24. PubMed ID: 20386465 [TBL] [Abstract][Full Text] [Related]
12. Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection. Tischer S; Geyeregger R; Kwoczek J; Heim A; Figueiredo C; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B J Transl Med; 2016 Oct; 14(1):286. PubMed ID: 27717382 [TBL] [Abstract][Full Text] [Related]
13. Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markers. Leibold J; Feucht J; Halder A; Stevanovic S; Kayser S; Handgretinger R; Feuchtinger T J Immunother; 2012; 35(9):661-9. PubMed ID: 23090075 [TBL] [Abstract][Full Text] [Related]
14. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering. Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014 [TBL] [Abstract][Full Text] [Related]
15. Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation. Locatelli F; Vinti L; Palumbo G; Rossi F; Bertaina A; Mastronuzzi A; Bernardo ME; Rutella S; Dellabona P; Giorgiani G; Moretta A; Moretta L Best Pract Res Clin Haematol; 2011 Sep; 24(3):339-49. PubMed ID: 21925087 [TBL] [Abstract][Full Text] [Related]
16. Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation. Perruccio K; Topini F; Tosti A; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A Blood Cells Mol Dis; 2008; 40(1):76-83. PubMed ID: 17977031 [TBL] [Abstract][Full Text] [Related]
17. T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant. Comoli P; Basso S; Labirio M; Baldanti F; Maccario R; Locatelli F Blood Cells Mol Dis; 2008; 40(1):68-70. PubMed ID: 17904879 [TBL] [Abstract][Full Text] [Related]
18. Single-cell cloning of human, donor-derived antileukemia T-cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reaction. Montagna D; Daudt L; Locatelli F; Montini E; Turin I; Lisini D; Giorgiani G; Bernardo ME; Maccario R Cancer Res; 2006 Jul; 66(14):7310-6. PubMed ID: 16849581 [TBL] [Abstract][Full Text] [Related]
19. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens. Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295 [TBL] [Abstract][Full Text] [Related]
20. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Tang J; Olive M; Champagne K; Flomenberg N; Eisenlohr L; Hsu S; Flomenberg P Gene Ther; 2004 Sep; 11(18):1408-15. PubMed ID: 15269714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]